FMP

FMP

Enter

TENX - Tenax Therapeutics, ...

Financial Summary of Tenax Therapeutics, Inc.(TENX), Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, an

photo-url-https://financialmodelingprep.com/image-stock/TENX.png

Tenax Therapeutics, Inc.

TENX

NASDAQ

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

3.36 USD

-0.07 (-2.08%)

About

ceo

Mr. Christopher T. Giordano

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax The...

CIK

0000034956

ISIN

US88032L6056

CUSIP

88032L209

Address

ONE Copley Parkway

Phone

919 855 2100

Country

US

Employee

5

IPO Date

Apr 4, 1994

Summary

CIK

0000034956

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

88032L209

ISIN

US88032L6056

Country

US

Price

3.36

Beta

2.19

Volume Avg.

24.18k

Market Cap

6.58M

Shares

-

52-Week

2.77-61.2

DCF

0.89

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.15

P/B

-

Website

https://www.tenaxthera.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest TENX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep